— OPINION —
If you care about food safety, then Jim Jones matters to you. A year into his tenure as Deputy Commissioner for the Human Foods Program, Jones has infused the
Congress is heating up to make some budget decisions just as temperatures in Washington, D.C., have turned hot. The Food and Drug Administration has requested $ 7.2 billion for
— OPINION —
By Steven Grossman, Executive Director of the Alliance for a Stronger FDA
Consistent with the overall discretionary spending targets set forth in last year’s budget agreement, the President’
The Alliance for a Stronger FDA is hosting Center Directors and other FDA senior leaders to discuss their portion of the the president’s Fiscal Year 2025 budget request (documents;
Until Food Safety News Managing Editor Coral Beach called me recently to talk about the relationship between the FDA’s budget and that of the entire federal government, it had
The reorganization of the Food and Drug Administration’s human foods programs was urgently needed and a long-time coming. The full plan still needs to go through review by Office
— COMMENTARY —
By Steven Grossman, executive director of the Alliance for a Stronger FDA
On Sept. 29, 2023, I fell asleep — certain that the government would shutdown at midnight the next
The FDA’s largest reorganization in history, involving about 8,000 employees, is far more than just “moving some boxes around.” The proposed changes and updates to an FDA-wide reorganization
— OPINION —
By Steven Grossman, Executive Director of the Alliance for a Stronger FDA.
What started as a crisis over the safety and supply of infant formula became a wide-ranging review
An Alliance for a Stronger FDA webinar on Monday, Nov. 13, will feature Jim Jones, FDA Deputy Commissioner for Human Foods. Alison Bodor of the American Frozen Foods Institute, and
Food safety was called out this year as the step-child of the Food and Drug Administration. And the FDA Commissioner who called for an outside review by Reagan-Udall Foundation did
The Alliance for a Stronger FDA — a stakeholder organization with 150+ groups and individuals devoted to advocating for increased appropriations for the FDA and educating policymakers and the public about
